De-identified patients at scale. Longitudinal PROs, procedures, diagnoses, medications, and utilization signals — continuously updated from real-world pain care settings. The benchmarking and external control layer that makes every evidence program more defensible.
*De-identified patient records in the PainRWD™ Science Cloud as of Q3 2026. A formal data descriptor is in preparation for peer-reviewed publication; figures will be updated on publication.
PainRWD™ Science Cloud has a specific, powerful role in Celéri Health's evidence infrastructure. Understanding what it is — and what it isn't — is what makes it useful.
PainRWD™ Science Cloud is purpose-built for the questions that can't be answered by a single site's data — or a single sponsor's cohort.
Contextualize your EaaS™ registry outcomes against real-world pain patients. Strengthen payer submissions by showing how your device or therapy performs relative to real-world standard of care — without running a parallel study.
Understand how pain treatments perform across diverse real-world populations — across indications, payer types, and geographies. Surface overuse, under-response, and true value. Structure value-based contracts with RWE that goes beyond what RCTs can show.
Size your target population before committing to a prospective study. Explore treatment patterns, responder characteristics, and outcome trajectories in your disease area. Pre-defined cohorts are ready for collaboration — no data collection required to start.
Real-world treatment pathways, cost signals, downstream utilization, and longitudinal outcomes — structured for health economic modeling. Accelerate dossier development without a standalone RWE study.
Science Cloud patients can be offered opt-in participation in custom surveys or private invitations to local provider education sessions. Define the target population by diagnosis, therapy, geography, or PRO profile — just like a research cohort.
Show how your therapy compares to existing standards of care in real-world settings. Support label expansion, post-market requirements, and publication with a comparator dataset built for methodological scrutiny.
Celéri Health has done the initial cohort definition work. Each disease community is a structured, pre-defined subset of the dataset — with longitudinal PROs, procedures, medications, and utilization signals already mapped.
Patients who underwent SCS trial and implant procedures — with longitudinal NRS, PGIC, PROMIS®-29, ZCQ, and ODI. Built for device sponsors seeking external control data or comparative benchmarking.
Outcomes across SI joint fusion procedures — posterior approach and beyond. Research endpoints structured for publication-ready analysis and payer dossier support.
The polypharmacy of pain patients — first-line vs. second-line therapies, longitudinal drug use, responder profiles, combinations, and downstream outcomes.
Continuously updating cohort of patients with active neoplasms or metastatic disease. Analyze pain interventions across cancer presentations, comorbid conditions, and treatment trajectories.
Stenosis, spondylolisthesis, failed back surgery, osteoarthritis, carpal and cubital tunnel, epicondylitis, ligament injuries, and migraine.
Painful diabetic neuropathy — peripheral, proximal, autonomic, and focal — with comorbid CVD, hypertension, and hyperlipidemia mapped alongside pain outcomes.
PainRWD™ Science Cloud sits alongside every EaaS™ engagement as a benchmarking and external control resource — and above point-of-care data capture as the aggregate intelligence layer. It doesn't replace the platform. It makes the platform more powerful.
A dataset is only as useful as its documentation. PainRWD™ Science Cloud is being described formally so that sponsors, payers, and reviewers can evaluate its provenance, structure, and limitations on the record.
Celéri Health is preparing a formal data descriptor for PainRWD™ Science Cloud — documenting data sources, de-identification methods, instrument coverage, cohort definitions, and known limitations — for submission to a peer-reviewed journal. Details will be shared on publication.
For sponsors, payers, and researchers who want their evidence contextualized against a documented, citable real-world dataset, now is the time to get familiar with it.
PainRWD™ Science Cloud integrates ZIP-level community SDOH data — food insecurity, housing instability, transportation access, economic stress — alongside clinical pain outcomes. Understanding why patients respond differently requires knowing the environment they live in, not just the procedures they received.
Individual-level SDOH matching is available through structured pathways with appropriate consent or IRB coverage. ZIP-level community data is immediately usable for population health analysis, payer contracting, and care gap identification.
Access to PainRWD™ Science Cloud is structured around your use case — from fast cohort analysis to deeply integrated sponsor benchmarking.
EaaS™ engagements include benchmarking of sponsor outcomes against the PainRWD™ dataset. Your Command Center shows how your cohort performs relative to the broader real-world pain population — by indication, payer, and geography — without a separate data access agreement.
Access one or more pre-defined disease communities for HEOR modeling, feasibility assessment, hypothesis generation, or payer dossier development. Celéri Health's data science team supports study design, analysis, and output formatting for your deliverable.
Clinician-researchers and academic institutions can collaborate with the Celéri Research Group to use PainRWD™ for investigator-initiated studies, hypothesis-driven publications, and grant-supported research. The dataset infrastructure is in place — you bring the scientific question.
Whether you're a sponsor looking for an external control group, a payer building a value-based framework, or a researcher with a hypothesis and no dataset — PainRWD™ Science Cloud is the starting point.
Site-based, non-research, growth-focused